New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S657

Introduced
1/9/24  

Caption

Establishes Children's Vaccine Adverse Event Reporting System.

Impact

The establishment of a Children's Vaccine Adverse Event Reporting System within the Department of Health is significant for public health. It mandates that healthcare providers report any adverse events experienced by children they administer vaccines to, thus contributing to pharmaceutical safety and pharmacovigilance. This reporting will facilitate data collection and analysis that can inform health policies and improve vaccination safety protocols, ultimately aiming to enhance public trust in immunization programs.

Summary

Senate Bill S657, known as the 'Children's Vaccine Adverse Event Reporting Act', aims to establish a reporting system for adverse events related to vaccines administered to children under the age of 19. The goal of this bill is to enhance the safety monitoring of vaccines by enabling healthcare professionals to report any medical occurrences that may arise within eight weeks following vaccination. The act recognizes the importance of vaccines in preventing infectious diseases while acknowledging that they can have side effects that require monitoring and investigation.

Contention

Discussions around S657 may include concerns regarding parental rights, transparency in reporting, and implications for healthcare providers. While many support the need for enhanced monitoring of vaccine safety, there may be apprehensions among some groups regarding the potential for over-reporting and the possible stigmatization of vaccines. Additionally, it's crucial to ensure that the identities of children and healthcare providers involved in these reports remain confidential, as the bill proposes.

Legislative context

This legislation aligns with federal statutes, including the National Childhood Vaccine Injury Act of 1986, which mandates some reporting but is intended to supplement and enhance state-level efforts. Its effectiveness will depend on the active participation of healthcare providers and public health entities in the reporting process, ensuring a comprehensive mechanism for monitoring adverse vaccine reactions.

Companion Bills

NJ A624

Same As Establishes Children's Vaccine Adverse Event Reporting System.

NJ S825

Carry Over Establishes Children's Vaccine Adverse Event Reporting System.

NJ A439

Carry Over Establishes Children's Vaccine Adverse Event Reporting System.

Similar Bills

NJ A624

Establishes Children's Vaccine Adverse Event Reporting System.

NJ A439

Establishes Children's Vaccine Adverse Event Reporting System.

NJ S825

Establishes Children's Vaccine Adverse Event Reporting System.

VA HB342

Naloxone or other opioid antagonists; possession by state agencies, guidelines for private employer.

VA SB647

Public health emergency; Comm. of Health to authorize administration, etc., of necessary drugs, etc.

VA HB939

Public health emergency; Comm. of Health to authorize administration, etc., of necessary drugs, etc.

VA SB1415

Opioids; impact reduction registry, report.

VA SB1257

Student & campus safety; opioid antagonist administration training for resident assistants required.